Edwards Lifesciences (EW) Stock Insights

EW$99.37—
Medical - DevicesLarge CapHigh Quality
Compare
Market cap$58.56BEnterprise value—Revenue (TTM)$6.67BMarket positionTop 25%

Score

47
Neutral
Value
21
Quality
76
Growth
44

Insights

  • Revenue by product
  • Revenue by region
Revenue by product
PeriodValue
FY2010Critical Care: 454100000.0, Surgical Heart Valve Therapy: 838300000.0
FY2011Critical Care: 508300000.0, Surgical Heart Valve Therapy: 1010700000.0
FY2012Critical Care: 560000000.0, Surgical Heart Valve Therapy: 787500000.0, Transcatheter Heart Valves: 552100000.0
FY2013Critical Care: 536600000.0, Surgical Heart Valve Therapy: 801200000.0, Transcatheter Heart Valves: 707700000.0
FY2014Critical Care: 553200000.0, Surgical Heart Valve Therapy: 826100000.0, Transcatheter Heart Valves: 943600000.0
FY2015Critical Care: 528400000.0, Surgical Heart Valve Therapy: 785000000.0, Transcatheter Heart Valves: 1180300000.0
FY2016Critical Care: 560300000.0, Surgical Heart Valve Therapy: 774900000.0, Transcatheter Heart Valves: 1628500000.0
FY2017Critical Care: 601000000.0, Surgical Heart Valve Therapy: 807100000.0, Transcatheter Heart Valves: 2027200000.0
FY2018Critical Care: 674500000.0, Surgical Heart Valve Therapy: 761600000.0, Transcatheter Heart Valves: 2286700000.0
FY2019Critical Care: 740200000.0, Surgical Heart Valve Therapy: 841700000.0, Transcatheter Heart Valves: 2737900000.0, Transcatheter Mitral And Tricuspid Therapies: 28200000.0
FY2020Critical Care: 725400000.0, Surgical Heart Valve Therapy: 761800000.0, Transcatheter Heart Valves: 2857300000.0, Transcatheter Mitral And Tricuspid Therapies: 41800000.0
FY2021Critical Care: 834900000.0, Surgical Heart Valve Therapy: 889100000.0, Transcatheter Heart Valves: 3422500000.0, Transcatheter Mitral And Tricuspid Therapies: 86000000.0
FY2022Critical Care: 855000000.0, Surgical Heart Valve Therapy: 893100000.0, Transcatheter Heart Valves: 3518200000.0, Transcatheter Mitral And Tricuspid Therapies: 116100000.0
FY2023Critical Care: 928100000.0, Surgical Heart Valve Therapy: 999300000.0, Transcatheter Heart Valves: 3879800000.0, Transcatheter Mitral And Tricuspid Therapies: 197600000.0
FY2024Surgical Heart Valve Therapy: 981300000.0, Transcatheter Heart Valves: 4106100000.0, Transcatheter Mitral And Tricuspid Therapies: 352100000.0
FY2025Surgical Heart Valve Therapy: 1029300000.0, Transcatheter Heart Valves: 4487700000.0, Transcatheter Mitral And Tricuspid Therapies: 550600000.0
Revenue by region
PeriodValue
FY2010Rest of World: 879400000.0, UNITED STATES: 567600000.0
FY2011Europe: 574000000.0, JAPAN: 283700000.0, Rest of World: 215300000.0, UNITED STATES: 605600000.0
FY2012Europe: 559700000.0, JAPAN: 294100000.0, Rest of World: 233700000.0, UNITED STATES: 812100000.0
FY2013Europe: 616500000.0, JAPAN: 243600000.0, Rest of World: 245800000.0, UNITED STATES: 939600000.0
FY2014Europe: 741400000.0, JAPAN: 270800000.0, UNITED STATES: 1047300000.0
FY2015Europe: 717300000.0, JAPAN: 246200000.0, Rest of World: 267300000.0, UNITED STATES: 1262900000.0
FY2016Europe: 749000000.0, JAPAN: 309300000.0, Rest of World: 289700000.0, UNITED STATES: 1615700000.0
FY2017Europe: 831000000.0, JAPAN: 350300000.0, Rest of World: 346400000.0, UNITED STATES: 1907600000.0
FY2018Europe: 885100000.0, JAPAN: 396800000.0, Rest of World: 385600000.0, UNITED STATES: 2055300000.0
FY2019Europe: 941200000.0, JAPAN: 444700000.0, Rest of World: 429400000.0, UNITED STATES: 2532700000.0
FY2020Europe: 973600000.0, JAPAN: 460100000.0, Rest of World: 435800000.0, UNITED STATES: 2516800000.0
FY2021Europe: 1190300000.0, JAPAN: 528900000.0, Rest of World: 550200000.0, UNITED STATES: 2963100000.0
FY2022Europe: 1174800000.0, JAPAN: 473600000.0, Rest of World: 601400000.0, UNITED STATES: 3132600000.0
FY2023Europe: 1334500000.0, JAPAN: 452400000.0, Rest of World: 709200000.0, UNITED STATES: 3508700000.0
FY2024Europe: 1321700000.0, JAPAN: 339800000.0, Rest of World: 572000000.0, UNITED STATES: 3206000000.0
FY2025Europe: 1517500000.0, JAPAN: 354700000.0, Rest of World: 652300000.0, UNITED STATES: 3543100000.0

Edwards Lifesciences (EW) Stock Insights

EW price $99.37 —

Ticker
EW
Price
$99.37
Change
—
Market cap
$58.56B
P/E
58.49
Forward P/E
31.93
Dividend yield
0.00%
Beta
0.83
Sector
Healthcare
Industry
Medical - Devices
Stocklytics score
47
Value
21
Quality
76
Growth
44

Stocklytics score rationale: value 21, quality 76, growth 44.

AI Score 70. Edwards Lifesciences Corporation has a strong market cap of $57.3 billion and impressive gross profit margins of approximately 78.1%. However, its high price-to-earnings ratio of 56.1 and negative price-to-earnings growth ratio indicate potential overvaluation, which may limit future growth prospects

Insights

Revenue by product
PeriodValue
FY2010Critical Care: 454100000.0, Surgical Heart Valve Therapy: 838300000.0
FY2011Critical Care: 508300000.0, Surgical Heart Valve Therapy: 1010700000.0
FY2012Critical Care: 560000000.0, Surgical Heart Valve Therapy: 787500000.0, Transcatheter Heart Valves: 552100000.0
FY2013Critical Care: 536600000.0, Surgical Heart Valve Therapy: 801200000.0, Transcatheter Heart Valves: 707700000.0
FY2014Critical Care: 553200000.0, Surgical Heart Valve Therapy: 826100000.0, Transcatheter Heart Valves: 943600000.0
FY2015Critical Care: 528400000.0, Surgical Heart Valve Therapy: 785000000.0, Transcatheter Heart Valves: 1180300000.0
FY2016Critical Care: 560300000.0, Surgical Heart Valve Therapy: 774900000.0, Transcatheter Heart Valves: 1628500000.0
FY2017Critical Care: 601000000.0, Surgical Heart Valve Therapy: 807100000.0, Transcatheter Heart Valves: 2027200000.0
FY2018Critical Care: 674500000.0, Surgical Heart Valve Therapy: 761600000.0, Transcatheter Heart Valves: 2286700000.0
FY2019Critical Care: 740200000.0, Surgical Heart Valve Therapy: 841700000.0, Transcatheter Heart Valves: 2737900000.0, Transcatheter Mitral And Tricuspid Therapies: 28200000.0
FY2020Critical Care: 725400000.0, Surgical Heart Valve Therapy: 761800000.0, Transcatheter Heart Valves: 2857300000.0, Transcatheter Mitral And Tricuspid Therapies: 41800000.0
FY2021Critical Care: 834900000.0, Surgical Heart Valve Therapy: 889100000.0, Transcatheter Heart Valves: 3422500000.0, Transcatheter Mitral And Tricuspid Therapies: 86000000.0
FY2022Critical Care: 855000000.0, Surgical Heart Valve Therapy: 893100000.0, Transcatheter Heart Valves: 3518200000.0, Transcatheter Mitral And Tricuspid Therapies: 116100000.0
FY2023Critical Care: 928100000.0, Surgical Heart Valve Therapy: 999300000.0, Transcatheter Heart Valves: 3879800000.0, Transcatheter Mitral And Tricuspid Therapies: 197600000.0
FY2024Surgical Heart Valve Therapy: 981300000.0, Transcatheter Heart Valves: 4106100000.0, Transcatheter Mitral And Tricuspid Therapies: 352100000.0
FY2025Surgical Heart Valve Therapy: 1029300000.0, Transcatheter Heart Valves: 4487700000.0, Transcatheter Mitral And Tricuspid Therapies: 550600000.0
Revenue by region
PeriodValue
FY2010Rest of World: 879400000.0, UNITED STATES: 567600000.0
FY2011Europe: 574000000.0, JAPAN: 283700000.0, Rest of World: 215300000.0, UNITED STATES: 605600000.0
FY2012Europe: 559700000.0, JAPAN: 294100000.0, Rest of World: 233700000.0, UNITED STATES: 812100000.0
FY2013Europe: 616500000.0, JAPAN: 243600000.0, Rest of World: 245800000.0, UNITED STATES: 939600000.0
FY2014Europe: 741400000.0, JAPAN: 270800000.0, UNITED STATES: 1047300000.0
FY2015Europe: 717300000.0, JAPAN: 246200000.0, Rest of World: 267300000.0, UNITED STATES: 1262900000.0
FY2016Europe: 749000000.0, JAPAN: 309300000.0, Rest of World: 289700000.0, UNITED STATES: 1615700000.0
FY2017Europe: 831000000.0, JAPAN: 350300000.0, Rest of World: 346400000.0, UNITED STATES: 1907600000.0
FY2018Europe: 885100000.0, JAPAN: 396800000.0, Rest of World: 385600000.0, UNITED STATES: 2055300000.0
FY2019Europe: 941200000.0, JAPAN: 444700000.0, Rest of World: 429400000.0, UNITED STATES: 2532700000.0
FY2020Europe: 973600000.0, JAPAN: 460100000.0, Rest of World: 435800000.0, UNITED STATES: 2516800000.0
FY2021Europe: 1190300000.0, JAPAN: 528900000.0, Rest of World: 550200000.0, UNITED STATES: 2963100000.0
FY2022Europe: 1174800000.0, JAPAN: 473600000.0, Rest of World: 601400000.0, UNITED STATES: 3132600000.0
FY2023Europe: 1334500000.0, JAPAN: 452400000.0, Rest of World: 709200000.0, UNITED STATES: 3508700000.0
FY2024Europe: 1321700000.0, JAPAN: 339800000.0, Rest of World: 572000000.0, UNITED STATES: 3206000000.0
FY2025Europe: 1517500000.0, JAPAN: 354700000.0, Rest of World: 652300000.0, UNITED STATES: 3543100000.0

Insights · Forecast · Financials · Learn

Stocklytics home · Screener